疫苗接种或自然感染诱导的流感病毒特异性抗体依赖性细胞介导的细胞毒性
本研究采用基于重组HA和表达FcγRIII(CD16)的连续NK细胞系的稳健ADCC检测法,评估人接种流感疫苗或感染后的ADCC应答。结果显示,接种佐剂三价季节性灭活疫苗、单价H1N1pdm09灭活疫苗以及感染H1N1pdm09病毒均可诱导HA特异性ADCC介导抗体;使用含H1茎部与禽病毒来源无关头部结构域的嵌合HA可检测H1茎部特异性ADCC介导抗体。该检测法有助于评估(通用)流感疫苗接种或感染后的ADCC介导血清抗体,并可能在未来将ADCC活性定义为(交叉)保护的相关指标。
要点
- 接种佐剂三价季节性灭活疫苗、单价H1N1pdm09灭活疫苗及感染H1N1pdm09病毒均可诱导HA特异性ADCC介导抗体。
- 基于重组HA和表达FcγRIII(CD16)的连续NK细胞系的ADCC检测法便于操作且可标准化。
- 嵌合HA(H1茎部+禽病毒无关头部)可检测H1茎部特异性ADCC介导抗体。
核心结论
- 接种佐剂三价季节性灭活疫苗、单价H1N1pdm09灭活疫苗以及感染H1N1pdm09病毒均可诱导HA特异性ADCC介导抗体。
- 使用含H1茎部与禽病毒来源无关头部结构域的嵌合HA可检测H1茎部特异性ADCC介导抗体。
- 该ADCC检测法有助于评估(通用)流感疫苗接种或感染后的ADCC介导血清抗体,并可能在未来将ADCC活性定义为(交叉)保护的相关指标。
研究设计与样本
- 本研究在人体中调查流感病毒疫苗接种或感染后的ADCC应答,采用基于重组HA和表达FcγRIII(CD16)的连续NK细胞系的稳健ADCC检测法。
主要发现
- 接种佐剂三价季节性灭活疫苗和单价H1N1pdm09灭活疫苗均可诱导HA特异性ADCC介导抗体。
- 感染H1N1pdm09病毒可诱导HA特异性ADCC介导抗体。
- 使用含H1茎部与禽病毒来源无关头部结构域的嵌合HA可检测H1茎部特异性ADCC介导抗体。
临床怎么用
- 该ADCC检测法便于操作且可标准化,有助于评估(通用)流感疫苗接种或感染后的ADCC介导血清抗体。
- 作者认为该检测法可能在未来将ADCC活性定义为(交叉)保护的相关指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza viruses are responsible for substantial morbidity and mortality during seasonal epidemics. Vaccination is the most effective method to prevent infection, however due to antigenic drift of the viral surface protein hemagglutinin (HA), annual influenza virus vaccination is required. In addition to seasonal viruses, certain (avian) influenza A viruses of other subtypes, like H5N1 or H7N9, cause sporadic zoonotic infections. Therefore, the availability of game-changing novel vaccines that induce "universal" immune responses to a wide variety of influenza A virus subtypes is highly desirable. The quest for universal influenza vaccines has fueled the interest in broadly-reactive antibodies specific for the stalk of hemagglutinin (HA) and biological activities of antibodies other than direct virus neutralization, like antibody-dependent cellular cytotoxicity (ADCC). In the present study, we investigated the ADCC response upon influenza virus vaccination and infection in humans using a robust ADCC assay that is based on the use of recombinant HA and a continuous NK cell line that expresses FcγRIII (CD16). This assay offers advantages over existing methods, like ease to perform and possibilities to standardize. We showed that HA-specific ADCC mediating antibodies are induced by vaccination with adjuvanted trivalent seasonal and monovalent H1N1pdm09 inactivated vaccines, and by infection with H1N1pdm09 virus. In addition, the use of chimeric influenza HA with a H1 stem but antigenically irrelevant head domain derived from an avian virus allowed detection of H1-stalk-specific ADCC mediating antibodies. This assay will facilitate the assessment of ADCC mediating serum antibodies after (universal) influenza vaccination or infection and may define ADCC activity as a correlate of (cross-) protection in the future.
引用
- de Vries RD, Nieuwkoop NJ, Pronk M, et al. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection. Vaccine. 2016. PMID: 27914742. doi:10.1016/j.vaccine.2016.11.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。